Literature DB >> 6209367

Interferon as adjuvant therapy with initial radiotherapy of patients with anaplastic gliomas.

M S Mahaley, M B Urso, R A Whaley, T E Williams, A Guaspari.   

Abstract

In a group of nine patients with anaplastic gliomas, survival following surgery and treatment with interferon and radiotherapy was comparable to survival for a matched group of patients treated with BCNU and radiotherapy following surgery.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6209367     DOI： 10.3171/jns.1984.61.6.1069

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


  5 in total

1.  Distribution of mouse interferon-beta in normal and brain tumour-bearing mice.

Authors:  Y Mihara; J Kuratsu; S Takaki; K Hori; E Nagai; Y Satoh; N Minowa; Y Ushio
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

2.  Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.

Authors:  R Martínez; J Vaquero; J Ramiro; F García Salazar; S De Oya
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study.

Authors:  K R von Wild; T H Knocke
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

4.  Intrathecal injection of autologous leucocytes in glioblastoma: circulatory dynamics within the subarachnoid space and clinical results.

Authors:  J Vaquero; R Martínez; L Barbolla; J de Haro; S de Oya; S Coca; J Ramiro
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

5.  Effect of interferon-beta on the cell cycle of human glioma cell line U-251 MG: flow cytometric two-dimensional (BrdU/DNA) analysis.

Authors:  S Genka; N Shitara; Y Tsujita; Y Kosugi; K Takakura
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.